Results With New Agents, New Approaches Highlighted At ASCO Annual Meeting
Taxol Plus Carboplatin Increased Survival Of NSCLC In Patients 70 And Older
New Therapies Could Benefit Patients With Difficult Cancers
Radiation Improves Survival In Advanced Prostate Cancer
Survivors With Gene Variant At More Risk For Heart Disease
ASCO, FDA Website To Help Demystify Expanded Access
NCI Trials Listed
Trending Stories
- Maura Gillison, who identified the role of HPV in head and neck cancer, changing the standard of care, dies at 61
- Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions
- Mail-out colorectal cancer screening programs extend, rather than replace, clinical care
- The future of oncology: Early-career scientists need mentorship and a new academic model
- The Directors: Two leaders in data science have a warp speed vision for AI, with cancer clinical trials leading the way
Knudsen and Thoelke: “It’s actually solving for bottlenecks and challenges that we’ve been unable to overcome for so long” - Abdallah Abou Zahr, an oncologist whose cancer story resonated widely, dies of liposarcoma at 42









